Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

Fig. 3

Cell viability after treatment with ABT199 in THP-1 and HL-60 cells transduced with 2 different CPT1a shRNAs a b,cCell viability after treatment with ST1326, ABT199 or combination in AML cell lines (b, up panel) and primary AML cells (c, up panel) measured by MTS assay. The combination index (CI) ( b,c down panel) was calculated using CalcuSyn software. The data are presented as mean ± SD format least three independent experiments for cell lines. For patient sample, the MTS assay was performed once due to limited sample

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us